Versor Investments LP bought a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 11,685 shares of the company’s stock, valued at approximately $86,000.
Several other hedge funds have also recently bought and sold shares of the company. Signaturefd LLC grew its holdings in shares of Nu Skin Enterprises by 72.6% during the 2nd quarter. Signaturefd LLC now owns 3,797 shares of the company’s stock valued at $40,000 after purchasing an additional 1,597 shares during the last quarter. Public Employees Retirement System of Ohio grew its holdings in Nu Skin Enterprises by 30.5% during the 1st quarter. Public Employees Retirement System of Ohio now owns 3,926 shares of the company’s stock worth $54,000 after acquiring an additional 918 shares during the last quarter. Covestor Ltd grew its holdings in Nu Skin Enterprises by 90.1% during the 1st quarter. Covestor Ltd now owns 4,353 shares of the company’s stock worth $60,000 after acquiring an additional 2,063 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in Nu Skin Enterprises during the 2nd quarter worth approximately $47,000. Finally, Lazard Asset Management LLC grew its holdings in Nu Skin Enterprises by 92.7% during the 1st quarter. Lazard Asset Management LLC now owns 4,587 shares of the company’s stock worth $63,000 after acquiring an additional 2,206 shares during the last quarter. 82.84% of the stock is owned by institutional investors.
Nu Skin Enterprises Stock Up 5.4 %
Nu Skin Enterprises stock opened at $7.58 on Monday. The company has a quick ratio of 1.20, a current ratio of 1.93 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises, Inc. has a 12-month low of $5.95 and a 12-month high of $20.75. The firm’s fifty day moving average is $6.74 and its 200 day moving average is $9.70. The company has a market capitalization of $376.73 million, a PE ratio of -3.66 and a beta of 1.14.
Nu Skin Enterprises Dividend Announcement
Wall Street Analyst Weigh In
NUS has been the topic of a number of recent analyst reports. Citigroup dropped their price target on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd. DA Davidson dropped their price target on shares of Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research report on Monday, August 12th. Finally, StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th.
Get Our Latest Stock Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
- Five stocks we like better than Nu Skin Enterprises
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in the FAANG Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.